(1) to assess the association between maternal folic acid fortification and the risk of CHD; (2) to determine the relationship between MTHFR gene polymorphisms and risk of CHD; (3) to explore the in
Additional file 1. Data for Fig. 2 data. Serum folate (A) and homocysteine (B) in CUMS rats after 6-week treatment of folic acid, Citalopram or saline.
